We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

- Multiple Sclerosis
- Completed

Study Title: A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxoneֲ® Therapy

Teva Identifier: PM08

ClinicalTrials.gov Identifier: NCT00238654

Study Status: Completed

Trial Condition(s): Multiple Sclerosis

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: 05/01/2003 - 07/01/2008

Study Type

Observational